CLINICAL_TRIALS
trial_result
· 2024-09-23
Clinical Trial Update: Study of Mirogabalin for Central Neuropathic Pain [Phase 3]
Summary
Results from a Phase 3 trial of Mirogabalin for central neuropathic pain have been posted following completion of the study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Central Neuropathic Pain | Phase 3 | Status: COMPLETED | Results posted: 2024-09-23